Abbvie Inc
BMV:ABBV
Abbvie Inc
BMV:ABBV
Price:
4 131.7998
MXN
Market Closed
Market Cap:
Mex$375.6B
Relative Value
The Relative Value of one
ABBV
stock under the Base Case scenario is
3 497.8389
MXN.
Compared to the current market price of 4 131.7998 MXN,
Abbvie Inc
is
Overvalued by 15%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABBV
Relative Value
Base Case
3 497.8389
MXN
Overvaluation 15%
Multiples Across Competitors
ABBV Competitors Multiples
Abbvie Inc Competitors
Abbvie Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Abbvie Inc
BMV:ABBV
|
402.1B MXN | 6.6 | 96.1 | 15.8 | 21.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD | 5.5 | 26.3 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182B USD | 6.2 | 21.4 | 13.3 | 16.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.1B USD | 9.8 | 29.6 | 22.3 | 23.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.6B USD | 5.8 | 18.3 | 13.8 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3.2 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
38.4B EUR | 10.9 | 35.1 | 38.1 | 38.9 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.8B USD | 11.5 | 136.7 | 76.2 | 84.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
